About Headlands Research
Headlands Research is a Healthcare company based in San Francisco (United States) founded in 2018, and was acquired by Thomas H Lee Partners in August 2025. Clinical research services are provided by Headlands Research globally. Headlands Research has completed 5 acquisitions, including AMCR Institute, Artemis Institute for Clinical Research and Clinvest. Headlands Research offers products and services including Clinical Trial Sites and Recruitment Services. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include BioQual, VGXI and ReveraGen.
Company details
Headlands Research was established in 2018 in San Francisco, United States, as a provider of clinical research services within the healthcare sector. Operations are centered on supporting clinical trials, including site management, patient recruitment, and data collection processes. Services are delivered to pharmaceutical and biotech clients, with a focus on efficient research execution. The company maintains its primary base in the United States, facilitating regional and national studies.
- Headquarters San Francisco, United States
- Stage Acquired
- SectorsHealthcare
- Website headlandsresearch.com
- Social LinkedIn X Facebook
- Acquired by Thomas H Lee Partners (Aug 2025)
- Investors
- Investments & AcquisitionsAMCR Institute
& 4 more
- Acquired byThomas H Lee Partners
(Aug 2025)
Products & Services of Headlands Research
Headlands Research offers a comprehensive portfolio of products and services, including Clinical Trial Sites and Recruitment Services.
Manages sites for conducting medical trials with diverse recruitment
Handles participant recruitment and retention for clinical studies
Investors in Headlands Research
Headlands Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Thomas H Lee Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward traditional industries. | 1974 | thl.com | Boston, United States |
Investor details for Headlands Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Headlands Research
45 people are tracked at Headlands Research (20 in leadership, 8 in board & advisors, 17 in team).
| Name | Role | Group |
|---|---|---|
Molly Brock | Executive Director Operations | Leadership |
Song Min Lee (Bsc | Site Director | Leadership |
Hank Heller | Director of Operations | Leadership |
Alana Wriggins | VP of Operations | Leadership |
Chris Cugliari | VP Of Corporate Development | Leadership |
David DeWees | Executive Director of Corporate Development, Integrated Site Business | Leadership |
Mark Blumling | CEO | Leadership |
Justin Brown | Director Of Accounting | Leadership |
Jordan Wertheimer | Director Of Business Development | Leadership |
Jackie Short | Chief Operating Officer | Leadership |
Autumn Huiatt | Chief Financial Officer | Leadership |
Christian S. | Vice President Marketing | Leadership |
Ccrc-Cp Joanne Stevens | Senior Director Of Regional Operations | Leadership |
Andrea Hunnicutt | Senior Director Of Operations | Leadership |
Kyle Burtnett | Chief Executive Officer | Leadership |
Laura T. | Chief People Officer | Leadership |
Mauro Ormedilla | Senior Regional Operations Director | Leadership |
Annette Garcia | Site Director | Leadership |
Christopher Romero | Medical Director | Leadership |
Kinan Hreib M.D. | Medical Director | Leadership |
25 more people are available in the full profile.
Complete people profiles for Headlands Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Headlands Research
Headlands Research has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include AMCR Institute, Artemis Institute for Clinical Research and Clinvest.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Clinical trials in gastroenterology and oncology are managed and coordinated. | trialmgt.com | Wilmington, United States | 2009 | Nov 2024 | •••• | |
Company offers clinical research studies and trial facilities for mental health disorders | pharmasiteresearch.com | Baltimore, United States | 1999 | Feb 2024 | •••• | |
Clinical research services are provided to clients worldwide. | amcrinstitute.com | Escondido, United States | 2007 | Jul 2023 | •••• | |
Site Management Organization, specializing in migraine related clinical trials | clinvest.com | Springfield, United States | 1996 | May 2023 | •••• | |
Phase I-IV drug development services for biopharma are provided. | artemis-research.com | San Diego, United States | 2008 | Feb 2021 | •••• |
Complete acquisition details for Headlands Research
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Headlands Research
7 dated milestones of Headlands Research across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Headlands Research is founded.
- Acquisition Acquires Artemis Institute for Clinical Research.
- Acquisition Acquires Clinvest.
- Acquisition Acquires AMCR Institute.
- Acquisition Acquires Pharmasite Research.
- Acquisition Acquires Trial Management Associates.
- Exit Acquired by Thomas H Lee Partners.
Competitors of Headlands Research
Headlands Research has 3 listed competitors in our database. They include BioQual, VGXI and ReveraGen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioqual.com | 1981 | Rockville, United States | 193 | Contract research on infectious disease models is conducted. | ||
| vgxii.com | 1997 | The Woodlands, United States | Contract developer and manufacturer of plasmids | |||
| reveragen.com | 2008 | Rockville, United States | Steroids for Duchenne muscular dystrophy treatment are developed. |
Detailed competitors of Headlands Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Headlands Research
The website of Headlands Research (headlandsresearch.com) receives about 7.8K visits a month.
- Monthly visits7.8K
▼ 12.5% vs previous month
Websites whose visitors overlap most with Headlands Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| headlandstech.com | 100% | 24.9K | #771,905 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Headlands Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Headlands Research
Complete news archive for Headlands Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Headlands Research
Headlands Research was founded in 2018.
Headlands Research is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Headlands Research was established in 2018 in San Francisco, United States, as a provider of clinical research services within the healthcare sector. Operations are centered on supporting clinical trials, including site management, patient recruitment, and data collection processes. Services are delivered to pharmaceutical and biotech clients, with a focus on efficient research execution. The company maintains its primary base in the United States, facilitating regional and national studies.
Headlands Research offers Clinical Trial Sites and Recruitment Services.
Headlands Research has made 5 acquisitions, including AMCR Institute, Artemis Institute for Clinical Research, and Clinvest.
Headlands Research has 1 investor. Key investors include Thomas H Lee Partners.
Yes. Headlands Research was acquired by Thomas H Lee Partners in August 2025.